识别代码中可替换为CAM算子的DeepEP算子，基于实际运行参数校验约束，自动完成通信域转换（NCCL->HCCL）、设备适配（CUDA->NPU）及算子替换。

跨会话检索聊天原文（记忆不足时再用）。在回答任何关于历史事件、日期、人物、过去对话的问题时，如果记忆中没有相关信息或不足以回答，则需要使用跨会话检索聊天原文。用 mcp_exec_command 执行 scripts/search_history.py，读 ~/.jiuwenclaw/agent/sessions/*/history.json。支持 channel、session_id、关键词、时间窗。如果搜索结果不足，尝试用不同的关键词再次搜索。

在用户提供 Chrome/Perfetto trace.json、或排查 Ascend 上 MoE/FusedDeepMoe 等算子性能时使用。按 phase、category、core group、tid 统计耗时、overlap、bubble，输出 CSV、Markdown 报告与确定性诊断；可选外部 LLM 扩写分析。默认 phase 映射面向 UMDK FusedDeepMoe，其它 trace 需替换或扩展 config/phase_map.yaml。

代理执行 AKG 算子任务。先检查固定仓库与分支；若 `~/.akg/check_env.md` 不存在则强制 `FULL_SETUP=true`；忽略所有 `akg_cli` 检查和使用；后端代码生成直接执行 `run_workflow.py --workflow kernelgen`。

进阶版日报生成器，支持多数据源采集、工作分析、趋势对比、周报月报聚合

Example custom agent skill — a template to get started.

Execute intentions through the environment.

Fetch the current world observation for this tick.

Persist important outcomes from this step to long-term storage with automatic forgetting curve.

Produce emotion.json and intention.json from workspace context.

Real-time hand detection in egocentric videos using victordibia/handtracking. Outputs bounding boxes for hands, specifically trained on EgoHands dataset. Supports video input/output with labeled hand boxes. Lightweight and fast for egocentric view applications.

Facebook Research Hand Tracking Challenge Toolkit - evaluation and visualization tools for 3D hand tracking. Supports loading HOT3D data, computing metrics (PA-MPJPE, AUC, etc.), visualizing 3D pose projections, and generating tracking evaluation reports. Essential for benchmarking hand tracking algorithms.

Egocentric Hand-Object Segmentation (EgoHOS) - pixel-level hand and object segmentation in egocentric videos. Outputs fine-grained segmentation masks with hand regions highlighted. Specialized for hand-object interaction scenarios with pixel-accurate masks. Ideal for detailed interaction analysis.

Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

Construct and analyze compound-target-disease networks for drug repurposing, polypharmacology discovery, and systems pharmacology. Builds multi-layer networks from ChEMBL, OpenTargets, STRING, DrugBank, Reactome, FAERS, and 60+ other ToolUniverse tools. Calculates Network Pharmacology Scores (0-100), identifies repurposing candidates, predicts mechanisms, and analyzes polypharmacology. Use when users ask about drug repurposing via network analysis, multi-target drug effects, compound-target-disease networks, systems pharmacology, or polypharmacology.

Comprehensive computational validation of drug targets for early-stage drug discovery. Evaluates targets across 10 dimensions (disambiguation, disease association, druggability, chemical matter, clinical precedent, safety, pathway context, validation evidence, structural insights, validation roadmap) using 60+ ToolUniverse tools. Produces a quantitative Target Validation Score (0-100) with GO/NO-GO recommendation. Use when users ask about target validation, druggability assessment, target prioritization, or "is X a good drug target for Y?"

Identify drug repurposing candidates using ToolUniverse for target-based, compound-based, and disease-driven strategies. Searches existing drugs for new therapeutic indications by analyzing targets, bioactivity, safety profiles, and literature evidence. Use when exploring drug repurposing opportunities, finding new indications for approved drugs, or when users mention drug repositioning, off-label uses, or therapeutic alternatives.

Comprehensive drug-drug interaction (DDI) prediction and risk assessment. Analyzes interaction mechanisms (CYP450, transporters, pharmacodynamic), severity classification, clinical evidence grading, and provides management strategies. Supports single drug pairs, polypharmacy analysis (3+ drugs), and alternative drug recommendations. Use when users ask about drug interactions, medication safety, polypharmacy risks, or need DDI assessment for clinical decision support.

Comprehensive chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, FDA label safety data, DrugBank safety profiles, and STITCH chemical-protein interactions. Performs predictive toxicology (AMES, DILI, LD50, carcinogenicity), organ/system toxicity profiling, chemical-gene-disease relationship mapping, regulatory safety extraction, and environmental hazard assessment. Use when asked about chemical toxicity, drug safety profiling, ADMET properties, environmental health risks, chemical hazard assessment, or toxicogenomic analysis.